Literature DB >> 19919945

Gene expression profile of fibrovascular membranes from patients with proliferative diabetic retinopathy.

Shigeo Yoshida1, Atsushi Ogura, Keijiro Ishikawa, Ayako Yoshida, Richiro Kohno, Yoko Yamaji, Kazuho Ikeo, Takashi Gojobori, Toshihiro Kono, Tatsuro Ishibashi.   

Abstract

BACKGROUND/AIMS: The purpose of this study was to generate a profile of genes expressed in preretinal fibrovascular membranes (FVMs) from patients with proliferative diabetic retinopathy.
METHODS: A PCR-amplified complementary DNA (cDNA) library was constructed using the RNAs isolated from FVMs obtained during vitrectomy. The sequence from the 5' end was obtained for randomly selected clones and used to generate expressed sequence tags (ESTs). Functional annotation was retrieved from Ensemble database and analysed by FatiGO. The web-based VisANT software was used to identify the molecular networks within the FVMs.
RESULTS: A total of 2816 ESTs were assembled in 625 non-redundant clusters. Among these, 515 matched the human cDNA database. The 515 clusters were subdivided by functional subsets of genes related to ribosomal activity, oxidative phosphorylation, focal adhesion, cell adhesion and other functions. Querying against the VisANT database yielded 3175 possible physical relationships to other genes/proteins, which included an additional 2480 genes that were not detected in the FVM library.
CONCLUSIONS: The cDNA library constructed from human FVMs will be a valuable source of information. It should facilitate a wide range of studies that can establish the molecular mechanisms underlying the development of FVMs.

Entities:  

Mesh:

Year:  2009        PMID: 19919945     DOI: 10.1136/bjo.2009.167072

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  5 in total

Review 1.  Periostin in vitreoretinal diseases.

Authors:  Shigeo Yoshida; Takahito Nakama; Keijiro Ishikawa; Shintaro Nakao; Koh-Hei Sonoda; Tatsuro Ishibashi
Journal:  Cell Mol Life Sci       Date:  2017-09-14       Impact factor: 9.261

2.  Inhibition of choroidal fibrovascular membrane formation by new class of RNA interference therapeutic agent targeting periostin.

Authors:  T Nakama; S Yoshida; K Ishikawa; Y Kobayashi; Y Zhou; S Nakao; Y Sassa; Y Oshima; K Takao; A Shimahara; K Yoshikawa; T Hamasaki; T Ohgi; H Hayashi; A Matsuda; A Kudo; M Nozaki; Y Ogura; M Kuroda; T Ishibashi
Journal:  Gene Ther       Date:  2014-12-11       Impact factor: 5.250

3.  Assessment of circulating fibrotic proteins (periostin and tenascin -C) In Type 2 diabetes mellitus patients with and without retinopathy.

Authors:  A Indumathi; Gandhipuram Periyaswamy Senthilkumar; Kuppuswamy Jayashree; K Ramesh Babu
Journal:  Endocrine       Date:  2022-03-10       Impact factor: 3.925

Review 4.  A Review of Last Decade Developments on Epiretinal Membrane Pathogenesis.

Authors:  Eleni Tsotridou; Eleftherios Loukovitis; Konstantinos Zapsalis; Iro Pentara; Solon Asteriadis; Paris Tranos; Zachos Zachariadis; George Anogeianakis
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2020-03-20

5.  Comparison of gene expression profile of epiretinal membranes obtained from eyes with proliferative vitreoretinopathy to that of secondary epiretinal membranes.

Authors:  Ryo Asato; Shigeo Yoshida; Atsushi Ogura; Takahito Nakama; Keijiro Ishikawa; Shintaro Nakao; Yukio Sassa; Hiroshi Enaida; Yuji Oshima; Kazuho Ikeo; Takashi Gojobori; Toshihiro Kono; Tatsuro Ishibashi
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.